WVE WAVE LIFE SCIENCES INC
Health Care · Russell 2000
Next earnings: not announced yet
What 26 analyst firms say about WAVE LIFE SCIENCES INC: their latest ratings, price targets and how far the stock is from them. How it works
Analyst window: Latest analyst report within last 1 year
Analyst view · last 1Y
23 rated views · 27 analyst/firm records · 26 firms
Radar score
- Russell 2000 · Top Picks · 6MNot scored · Price below 5 USD
- Russell 2000 · Safest consensus · 6MNot scored · Price below 5 USD
Recent analyst activity · last 90 days
Our tracked history has 16 reports on WVE from 13 analyst firms in the last 90 days (26 firms in the past year).
Comparing each firm's latest target with its previous one: 2 raised their price target, 2 lowered it, 3 left it unchanged and 2 have their first observed target in the past year.
No firm's latest available rating differs from its previous one.
Latest observed target change: Canaccord Genuity raised its target from $43.00 (set 30 Apr 2026) to $44.00 on 29 Oct 2026.
Last 1 year. Latest opinion per identifiable analyst within the last 1 year. BUY / HOLD / SELL each count one current analyst vote; unnamed firm records are a fallback.
| Firm | Analyst | Latest rating | Report date | Latest target (USD) |
|---|---|---|---|---|
| B Riley Securities | Madison El-Saadi | Buy | 31 Jul 2026 | 22.00 USD |
| Bank of America Securities | Alec Stranahan | Buy | 27 Mar 2026 | 21.00 USD |
| Canaccord Genuity | Whitney Ijem | Buy | 29 Oct 2026 | 44.00 USD |
| Cantor Fitzgerald | Steve Seedhouse | Buy | 28 Oct 2026 | 12.00 USD |
| Citigroup | Samantha Semenkow | Buy | 31 Jul 2026 | 19.00 USD |
| Clear Street | Unnamed analyst | Buy | 9 Dec 2025 | 47.00 USD |
| Clear Street LLC | Kaveri Pohlman | Buy | 1 May 2026 | 26.00 USD |
| H.C. Wainwright | Ananda Ghosh | Buy | 28 Oct 2026 | 13.00 USD |
| H.C. Wainwright | Andrew S. Fein | Buy | 28 Oct 2026 | 13.00 USD · 31 Jul 2026 |
| Jefferies | Roger Song | Buy | 31 Jul 2026 | 14.00 USD |
| Jonestrading | Catherine Novack | Buy | 7 Aug 2026 | Conflicting reports · excluded |
| JPMorgan | Tessa Romero | Hold | 23 Sep 2026 | — |
| Ladenburg Thalmann | Rick Bienkowski | Buy | 1 Oct 2026 | 10.00 USD |
| Leerink Partners | Joseph P Schwartz | Buy | 30 Jul 2026 | Conflicting reports · excluded |
| Mizuho | Salim Syed | Buy | 4 Aug 2026 | 23.00 USD |
| Morgan Stanley | Unnamed analyst | — | 8 Dec 2025 | 28.00 USD |
| New Street Research | Unnamed analyst | — | 11 Jun 2026 | 13.00 USD |
| Oppenheimer | Cheng Li | Buy | 16 Dec 2025 | 32.00 USD |
| Raymond James | Martin Auster | Buy | 30 Jul 2026 | — |
| RBC Capital Markets | Luca Issi | Buy | 31 Jul 2026 | 15.00 USD |
| Truist | Danielle Brill | Buy | 31 Jul 2026 | 15.00 USD |
| UBS | Joon Lee | Buy | 15 Oct 2026 | 11.00 USD |
| Wedbush | Yun Zhong | — | 2 Oct 2026 | 13.00 USD |
| Weiss Ratings | Unnamed analyst | — | 15 Oct 2026 | — |
| Wells Fargo | Benjamin Burnett | Buy | 2 Sep 2026 | 14.00 USD |
| William Blair | Alethia Young | Buy | 16 Oct 2026 | — |
| Data feed RESEARCH | Research Team | Hold | 19 Aug 2026 | — |
Partial coverage · checked 6 Nov (6 Nov 2026, 06:16 ET). Some research records could not be refreshed. Cached records retained. Prices stream live during the US session; otherwise stored prices delayed about 15 minutes. A summary of analyst opinion, not investment advice.